[Pulmonary embolism and diffuse alveolar bleeding: combination options and therapy features]

Area of Science:

• Rheumatology and Pulmonology
• Pathophysiology of autoimmune diseases
• Clinical diagnostics and treatment

Context:

• Systemic vasculitis, including granulomatosis with polyangiitis, systemic lupus erythematosus, and antiphospholipid syndrome, can lead to severe complications.
• Pulmonary embolism (PE) and diffuse alveolar hemorrhage (DAH) are rare but potentially fatal manifestations.
• Understanding the interplay between PE and DAH is crucial for effective patient management.

Purpose:

• To analyze the mechanisms behind the rare co-occurrence of PE and DAH in systemic vasculitis.
• To review existing literature on this specific combination of complications.
• To propose a working classification and therapeutic approach for PE and DAH.

Summary:

• The study investigates the formation of PE and DAH in conditions like granulomatosis with polyangiitis and lupus erythematosus.
• It considers three temporal patterns: DAH preceding PE, PE preceding DAH, or simultaneous onset.
• A review of case reports, proposed criteria, and a severity classification are presented, alongside a modern therapeutic program.

Impact:

• Provides a framework for diagnosing and classifying the combined PE and DAH in vasculitis patients.
• Offers guidance for developing tailored treatment strategies for these critical conditions.
• Aims to improve outcomes for patients experiencing these severe pulmonary complications.